Within-host heterogeneity of mycobacterium tuberculosis infection is associated with poor early treatment response: A prospective cohort study

Journal of Infectious Diseases

Volumn 213, Issue 11, 2016, Pages 1796-1799

  Cohen, Ted ^a   Chindelevitch, Leonid ^a   Misra, Reshma ^d   Kempner, Maria E ^b   Galea, Jerome ^c   Moodley, Prashini ^d   Wilson, Douglas ^d  

^a YALE UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c PARTNERS IN HEALTH   (United States)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Coinfection; HIV TB; Mixed infection; Tuberculosis; Within host heterogeneity

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERSPERSED REPEAT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SOUTH AFRICA; SPUTUM CULTURE; TREATMENT RESPONSE; VARIABLE NUMBER OF TANDEM REPEAT; WITHIN HOST HETEROGENEITY; COMPLICATION; FOLLOW UP; GENETICS; MICROBIOLOGY; SPUTUM; TIME TO TREATMENT; TUBERCULOSIS, PULMONARY;

ADULT; ANTITUBERCULAR AGENTS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC HETEROGENEITY; HIV INFECTIONS; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SOUTH AFRICA; SPUTUM; TIME-TO-TREATMENT; TUBERCULOSIS, PULMONARY;

EID: 84978643542     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw014     Document Type: Article

References (15)

1. Zetola NM, Shin SS, Tumedi KA, et al. Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. J Clin Microbiol 2014; 52:2422-9.
2. Zetola NM, Modongo C, Moonan PK, et al. Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests. J Infect Dis 2014; 209:1754-63.
3. van Rie A, Victor TC, Richardson M, et al. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Crit Care Med 2005; 172:636-42.
4. Liu Q, Via LE, Luo T, et al. Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment. Sci Rep 2015; 5:17507.
5. Cohen T, van Helden PD, Wilson D, et al. Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clin Microbiol Rev 2012; 25:708-19.
6. KwaZulu-Natal Department of Health Annual Report 2013:[54 p.]. http://www. kznhealth.gov.za/AnnualReport/2013-2014.pdf. Accessed 20 September 2015.
7. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42:377-81.
8. Hanekom M, Streicher EM, Van de Berg D, et al. Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependent. PLoS One 2013; 8:e70178.
9. Oelemann MC, Diel R, Vatin V, et al. Assessment of an optimized mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis. J Clin Microbiol 2007; 45:691-7.
10. Garcia de Viedma D, Alonso Rodriguez N, Andres S, Ruiz Serrano MJ, Bouza E. Characterization of clonal complexity in tuberculosis by mycobacterial interspersed repetitive unit-variable-number tandem repeat typing. J Clin Microbiol 2005; 43:5660-4.
11. Cohen T, Wilson D,Wallengren K, Samuel EY, Murray M. Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa. J Clin Microbiol 2011; 49:385-8.
12. Shin SS, Modongo C, Ncube R, Sepako E, Klausner JD, Zetola NM. Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant tuberculosis in Botswana. J Infect Dis 2015; 211:347-51.
13. Colman RE, Schupp JM, Hicks ND, et al. Detection of low-level mixed-population drug resistance in Mycobacterium tuberculosis using high fidelity amplicon sequencing. PLoS One 2015; 10:e0126626.
14. Brown AC, Bryant JM, Einer-Jensen K, et al. Rapid whole-genome sequencing of Mycobacterium tuberculosis directly from clinical samples. J Clin Microbiol 2015; 53:2230-7.
15. Perez-Lago L, Palacios JJ, Herranz M, Ruiz Serrano MJ, Bouza E, Garcia-de-Viedma D. Revealing hidden clonal complexity in Mycobacterium tuberculosis infection by qualitative and quantitative improvement of sampling. Clin Microbiol Infect 2015; 21:147.e1-7.